首页> 外文期刊>Trends in Endocrinology and Metabolism: TEM >Role of metabolic lipases and lipolytic metabolites in the pathogenesis of NAFLD.
【24h】

Role of metabolic lipases and lipolytic metabolites in the pathogenesis of NAFLD.

机译:代谢脂肪酶和脂解代谢产物在NAFLD发病机理中的作用。

获取原文
获取原文并翻译 | 示例
       

摘要

Non-alcoholic fatty liver disease (NAFLD) is the most frequent chronic liver disease in Western countries, ranging from simple steatosis to steatohepatitis, cirrhosis, and hepatocellular cancer. Although the mechanisms underlying disease progression are incompletely understood, lipotoxic events in the liver resulting in inflammation and fibrosis appear to be central. Free fatty acids and their metabolites are potentially lipotoxic mediators triggering liver injury, suggesting a central role for metabolic lipases. These enzymes are major players in lipid partitioning between tissues and within cells, and provide ligands for nuclear receptors (NRs). We discuss the potential role of intracellular lipases and their lipolytic products in NAFLD. Because tissue-specific modulation of lipases is currently impossible, targeting NRs with ligands may open novel therapeutic perspectives.
机译:非酒精性脂肪肝疾病(NAFLD)是西方国家最常见的慢性肝病,范围从单纯性脂肪变性到脂肪性肝炎,肝硬化和肝细胞癌。尽管尚未完全理解疾病进展的机制,但肝脏中导致炎症和纤维化的脂毒性事件似乎很重要。游离脂肪酸及其代谢物是潜在的脂毒性介质,可引发肝损伤,提示代谢脂肪酶起着核心作用。这些酶是脂质在组织之间和细胞内分配的主要参与者,并为核受体(NRs)提供配体。我们讨论了细胞内脂肪酶及其脂解产物在NAFLD中的潜在作用。由于目前尚无法对脂肪酶进行组织特异性调节,因此用配体靶向NRs可能会开辟新的治疗前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号